share_log

Merck Says Health Canada Approved KEYTRUDA Combination As First-line Treatment For Adult Patients With Locally Advanced Unresectable Or Metastatic HER2-Negative Gastric Or GEJ Adenocarcinoma

Merck Says Health Canada Approved KEYTRUDA Combination As First-line Treatment For Adult Patients With Locally Advanced Unresectable Or Metastatic HER2-Negative Gastric Or GEJ Adenocarcinoma

默沙東表示，加拿大衛生部批准將KEYTRUDA組合作爲局部晚期不可切除或轉移性HER2陰性胃癌或GEJ腺癌成年患者的一線治療方法
Benzinga ·  04/19 19:07

Merck Says Health Canada Approved KEYTRUDA Combination As First-line Treatment For Adult Patients With Locally Advanced Unresectable Or Metastatic HER2-Negative Gastric Or GEJ Adenocarcinoma

默沙東表示，加拿大衛生部批准將KEYTRUDA組合作爲局部晚期不可切除或轉移性HER2陰性胃癌或GEJ腺癌成年患者的一線治療方法

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論